Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 15 entries
Sorted by: Best Match Show Resources per page
Administration of D-Alanine-[Ang-(1-7)] (A-779) Prior to Pregnancy in Sprague Dawley Rats Produces Antidiuresis in Late Gestation.

Journal of the American Society of Hypertension : JASH

Joyner J, Neves L, Ferrario C, Brosnihan K.
PMID: 19198668
J Am Soc Hypertens. 2008;2(6):425-430. doi: 10.1016/j.jash.2008.05.002.

We previously demonstrated that angiotensin-(1-7) [Ang-(1-7)], which is increased in the kidney and urine during pregnancy, influences normal fluid expansion of pregnancy. These previous studies were completed by chronic administration of the Ang-(1-7) receptor antagonist D-Alanine-[Ang-(1-7)] (A-779) at a...

Cite
Joyner J, Neves L, Ferrario C, et al. Administration of D-Alanine-[Ang-(1-7)] (A-779) Prior to Pregnancy in Sprague Dawley Rats Produces Antidiuresis in Late Gestation. J Am Soc Hypertens. 2008;2(6):425-430doi: 10.1016/j.jash.2008.05.002.
Joyner, J., Neves, L., Ferrario, C., & Brosnihan, K. (2008). Administration of D-Alanine-[Ang-(1-7)] (A-779) Prior to Pregnancy in Sprague Dawley Rats Produces Antidiuresis in Late Gestation. Journal of the American Society of Hypertension : JASH, 2(6), 425-430. https://doi.org/10.1016/j.jash.2008.05.002
Joyner, J, et al. "Administration of D-Alanine-[Ang-(1-7)] (A-779) Prior to Pregnancy in Sprague Dawley Rats Produces Antidiuresis in Late Gestation." Journal of the American Society of Hypertension : JASH vol. 2,6 (2008): 425-430. doi: https://doi.org/10.1016/j.jash.2008.05.002
Joyner J, Neves L, Ferrario C, Brosnihan K. Administration of D-Alanine-[Ang-(1-7)] (A-779) Prior to Pregnancy in Sprague Dawley Rats Produces Antidiuresis in Late Gestation. J Am Soc Hypertens. 2008;2(6):425-430. doi: 10.1016/j.jash.2008.05.002. PMID: 19198668; PMCID: PMC2636960.
Copy Download .nbib Format: NLM
Successful use of an automated proning system to achieve prone positioning in a patient with severe ARDS requiring veno-venous ECMO.

Respiratory medicine case reports

Lehr AL, Smith DE, Toy B, Goldenberg R, Brosnahan SB.
PMID: 33335831
Respir Med Case Rep. 2020 Dec 04;31:101315. doi: 10.1016/j.rmcr.2020.101315. eCollection 2020.

A morbidly obese middle aged woman in her 40's presented to another hospital with methicillin resistant staphylococcus aureus pneumonia and subsequently developed severe acute respiratory distress syndrome. Her oxygenation demonstrated no improvement with low tidal volume ventilation, paralysis, or...

Cite
Lehr AL, Smith DE, Toy B, et al. Successful use of an automated proning system to achieve prone positioning in a patient with severe ARDS requiring veno-venous ECMO. Respir Med Case Rep. 2020;31:101315doi: 10.1016/j.rmcr.2020.101315.
Lehr, A. L., Smith, D. E., Toy, B., Goldenberg, R., & Brosnahan, S. B. (2020). Successful use of an automated proning system to achieve prone positioning in a patient with severe ARDS requiring veno-venous ECMO. Respiratory medicine case reports, 31101315. https://doi.org/10.1016/j.rmcr.2020.101315
Lehr, Andrew L, et al. "Successful use of an automated proning system to achieve prone positioning in a patient with severe ARDS requiring veno-venous ECMO." Respiratory medicine case reports vol. 31 (2020): 101315. doi: https://doi.org/10.1016/j.rmcr.2020.101315
Lehr AL, Smith DE, Toy B, Goldenberg R, Brosnahan SB. Successful use of an automated proning system to achieve prone positioning in a patient with severe ARDS requiring veno-venous ECMO. Respir Med Case Rep. 2020 Dec 04;31:101315. doi: 10.1016/j.rmcr.2020.101315. eCollection 2020. PMID: 33335831; PMCID: PMC7734294.
Copy Download .nbib Format: NLM
Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats.

Physiological reports

Schaich CL, Shaltout HA, Brosnihan KB, Howlett AC, Diz DI.
PMID: 25168868
Physiol Rep. 2014 Aug 28;2(8). doi: 10.14814/phy2.12108. Print 2014 Aug 01.

We investigated acute and chronic effects of CB1 cannabinoid receptor blockade in renin-angiotensin system-dependent hypertension using rimonabant (SR141716A), an orally active antagonist with central and peripheral actions. In transgenic (mRen2)27 rats, a model of angiotensin II-dependent hypertension with increased...

Cite
Schaich CL, Shaltout HA, Brosnihan KB, et al. Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats. Physiol Rep. 2014;2(8)doi: 10.14814/phy2.12108.
Schaich, C. L., Shaltout, H. A., Brosnihan, K. B., Howlett, A. C., & Diz, D. I. (2014). Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats. Physiological reports, 2(8), . https://doi.org/10.14814/phy2.12108
Schaich, Chris L, et al. "Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats." Physiological reports vol. 2,8 (2014). doi: https://doi.org/10.14814/phy2.12108
Schaich CL, Shaltout HA, Brosnihan KB, Howlett AC, Diz DI. Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats. Physiol Rep. 2014 Aug 28;2(8). doi: 10.14814/phy2.12108. Print 2014 Aug 01. PMID: 25168868; PMCID: PMC4246581.
Copy Download .nbib Format: NLM
Pharmacologic neuroprotection in ischemic brain injury after cardiac arrest.

Annals of the New York Academy of Sciences

Katz A, Brosnahan SB, Papadopoulos J, Parnia S, Lam JQ.
PMID: 34060087
Ann N Y Acad Sci. 2021 May 31; doi: 10.1111/nyas.14613. Epub 2021 May 31.

Cardiac arrest has many implications for morbidity and mortality. Few interventions have been shown to improve return of spontaneous circulation (ROSC) and long-term outcomes after cardiac arrest. Ischemic-reperfusion injury upon achieving ROSC creates an imbalance between oxygen supply and...

Cite
Katz A, Brosnahan SB, Papadopoulos J, et al. Pharmacologic neuroprotection in ischemic brain injury after cardiac arrest. Ann N Y Acad Sci. 2021;doi: 10.1111/nyas.14613.
Katz, A., Brosnahan, S. B., Papadopoulos, J., Parnia, S., & Lam, J. Q. (2021). Pharmacologic neuroprotection in ischemic brain injury after cardiac arrest. Annals of the New York Academy of Sciences, . https://doi.org/10.1111/nyas.14613
Katz, Alyson, et al. "Pharmacologic neuroprotection in ischemic brain injury after cardiac arrest." Annals of the New York Academy of Sciences vol. (2021). doi: https://doi.org/10.1111/nyas.14613
Katz A, Brosnahan SB, Papadopoulos J, Parnia S, Lam JQ. Pharmacologic neuroprotection in ischemic brain injury after cardiac arrest. Ann N Y Acad Sci. 2021 May 31; doi: 10.1111/nyas.14613. Epub 2021 May 31. PMID: 34060087.
Copy Download .nbib Format: NLM
Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19.

Resuscitation plus

Yuriditsky E, Mitchell OJL, Brosnahan SB, Smilowitz NR, Drus KW, Gonzales AM, Xia Y, Parnia S, Horowitz JM.
PMID: 33403368
Resusc Plus. 2020 Dec;4:100054. doi: 10.1016/j.resplu.2020.100054. Epub 2020 Nov 21.

AIMS: To define outcomes of patients with COVID-19 compared to patients without COVID-19 suffering in-hospital cardiac arrest (IHCA).MATERIALS AND METHODS: We performed a single-center retrospective study of IHCA cases. Patients with COVID-19 were compared to consecutive patients without COVID-19...

Cite
Yuriditsky E, Mitchell OJL, Brosnahan SB, et al. Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19. Resusc Plus. 2020;4:100054doi: 10.1016/j.resplu.2020.100054.
Yuriditsky, E., Mitchell, O. J. L., Brosnahan, S. B., Smilowitz, N. R., Drus, K. W., Gonzales, A. M., Xia, Y., Parnia, S., & Horowitz, J. M. (2020). Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19. Resuscitation plus, 4100054. https://doi.org/10.1016/j.resplu.2020.100054
Yuriditsky, Eugene, et al. "Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19." Resuscitation plus vol. 4 (2020): 100054. doi: https://doi.org/10.1016/j.resplu.2020.100054
Yuriditsky E, Mitchell OJL, Brosnahan SB, Smilowitz NR, Drus KW, Gonzales AM, Xia Y, Parnia S, Horowitz JM. Clinical characteristics and outcomes of in-hospital cardiac arrest among patients with and without COVID-19. Resusc Plus. 2020 Dec;4:100054. doi: 10.1016/j.resplu.2020.100054. Epub 2020 Nov 21. PMID: 33403368; PMCID: PMC7680084.
Copy Download .nbib Format: NLM
Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic.

The Journal of invasive cardiology

Talmor N, Ramachandran A, Brosnahan SB, Shah B, Bangalore S, Razzouk L, Attubato M, Feit F, Thompson C, Smilowitz NR.
PMID: 34866048
J Invasive Cardiol. 2021 Dec 05; Epub 2021 Dec 05.

BACKGROUND: The initial wave of the coronavirus disease 2019 (COVID-19) pandemic resulted in an influx of patients with acute viral illness and profound changes in healthcare delivery in New York City. The impact of this pandemic on the presentation...

Cite
Talmor N, Ramachandran A, Brosnahan SB, et al. Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. J Invasive Cardiol. 2021;
Talmor, N., Ramachandran, A., Brosnahan, S. B., Shah, B., Bangalore, S., Razzouk, L., Attubato, M., Feit, F., Thompson, C., & Smilowitz, N. R. (2021). Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. The Journal of invasive cardiology, .
Talmor, Nina, et al. "Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic." The Journal of invasive cardiology vol. (2021).
Talmor N, Ramachandran A, Brosnahan SB, Shah B, Bangalore S, Razzouk L, Attubato M, Feit F, Thompson C, Smilowitz NR. Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. J Invasive Cardiol. 2021 Dec 05; Epub 2021 Dec 05. PMID: 34866048.
Copy Download .nbib Format: NLM
Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.

The Annals of pharmacotherapy

Chen XJC, Altshuler D, Spiegler P, Brosnahan SB.
PMID: 34330173
Ann Pharmacother. 2021 Jul 30;10600280211036047. doi: 10.1177/10600280211036047. Epub 2021 Jul 30.

No abstract available.

Cite
Chen XJC, Altshuler D, Spiegler P, et al. Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk. Ann Pharmacother. 2021;10600280211036047doi: 10.1177/10600280211036047.
Chen, X. J. C., Altshuler, D., Spiegler, P., & Brosnahan, S. B. (2021). Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk. The Annals of pharmacotherapy, 10600280211036047. https://doi.org/10.1177/10600280211036047
Chen, Xian Jie Cindy, et al. "Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk." The Annals of pharmacotherapy vol. (2021): 10600280211036047. doi: https://doi.org/10.1177/10600280211036047
Chen XJC, Altshuler D, Spiegler P, Brosnahan SB. Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk. Ann Pharmacother. 2021 Jul 30;10600280211036047. doi: 10.1177/10600280211036047. Epub 2021 Jul 30. PMID: 34330173.
Copy Download .nbib Format: NLM
Risk of thrombotic events after respiratory infection requiring hospitalization.

Scientific reports

Smilowitz NR, Subashchandran V, Newman J, Barfield ME, Maldonado TS, Brosnahan SB, Yuriditsky E, Horowitz JM, Shah B, Reynolds HR, Hochman JS, Berger JS.
PMID: 33602977
Sci Rep. 2021 Feb 18;11(1):4053. doi: 10.1038/s41598-021-83466-9.

Thrombosis is a major concern in respiratory infections. Our aim was to investigate the magnitude and duration of risk for arterial and venous thrombosis following discharge after respiratory infection. Patients with respiratory infections were identified using the United States...

Cite
Smilowitz NR, Subashchandran V, Newman J, et al. Risk of thrombotic events after respiratory infection requiring hospitalization. Sci Rep. 2021;11(1):4053doi: 10.1038/s41598-021-83466-9.
Smilowitz, N. R., Subashchandran, V., Newman, J., Barfield, M. E., Maldonado, T. S., Brosnahan, S. B., Yuriditsky, E., Horowitz, J. M., Shah, B., Reynolds, H. R., Hochman, J. S., & Berger, J. S. (2021). Risk of thrombotic events after respiratory infection requiring hospitalization. Scientific reports, 11(1), 4053. https://doi.org/10.1038/s41598-021-83466-9
Smilowitz, Nathaniel R, et al. "Risk of thrombotic events after respiratory infection requiring hospitalization." Scientific reports vol. 11,1 (2021): 4053. doi: https://doi.org/10.1038/s41598-021-83466-9
Smilowitz NR, Subashchandran V, Newman J, Barfield ME, Maldonado TS, Brosnahan SB, Yuriditsky E, Horowitz JM, Shah B, Reynolds HR, Hochman JS, Berger JS. Risk of thrombotic events after respiratory infection requiring hospitalization. Sci Rep. 2021 Feb 18;11(1):4053. doi: 10.1038/s41598-021-83466-9. PMID: 33602977; PMCID: PMC7893015.
Copy Download .nbib Format: NLM
Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic.

The Journal of invasive cardiology

Talmor N, Ramachandran A, Brosnahan SB, Shah B, Bangalore S, Razzouk L, Attubato M, Feit F, Thompson C, Smilowitz NR.
PMID: 34866048
J Invasive Cardiol. 2022 Jan;34(1):E32-E38. Epub 2021 Dec 05.

BACKGROUND: The initial wave of the coronavirus disease 2019 (COVID-19) pandemic resulted in an influx of patients with acute viral illness and profound changes in healthcare delivery in New York City. The impact of this pandemic on the presentation...

Cite
Talmor N, Ramachandran A, Brosnahan SB, et al. Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. J Invasive Cardiol. 2021;34(1):E32-E38
Talmor, N., Ramachandran, A., Brosnahan, S. B., Shah, B., Bangalore, S., Razzouk, L., Attubato, M., Feit, F., Thompson, C., & Smilowitz, N. R. (2022). Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. The Journal of invasive cardiology, 34(1), E32-E38.
Talmor, Nina, et al. "Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic." The Journal of invasive cardiology vol. 34,1 (2022): E32-E38.
Talmor N, Ramachandran A, Brosnahan SB, Shah B, Bangalore S, Razzouk L, Attubato M, Feit F, Thompson C, Smilowitz NR. Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. J Invasive Cardiol. 2022 Jan;34(1):E32-E38. Epub 2021 Dec 05. PMID: 34866048.
Copy Download .nbib Format: NLM
Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats.

Journal of the American Society of Hypertension : JASH

Jessup JA, Brosnihan KB, Gallagher PE, Chappell MC, Ferrario CM.
PMID: 19343087
J Am Soc Hypertens. 2008 Mar-Apr;2(2):106-15. doi: 10.1016/j.jash.2007.10.005.

Fifty years since their introduction, thiazide diuretics are established as first-line therapy in the treatment of hypertension. Because the dosing profile for thiazide agents lessened, the mechanism responsible for the blood pressure lowering effect may lie outside their diuretic...

Cite
Jessup JA, Brosnihan KB, Gallagher PE, et al. Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats. J Am Soc Hypertens. 2008;2(2):106-15doi: 10.1016/j.jash.2007.10.005.
Jessup, J. A., Brosnihan, K. B., Gallagher, P. E., Chappell, M. C., & Ferrario, C. M. (2008). Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats. Journal of the American Society of Hypertension : JASH, 2(2), 106-15. https://doi.org/10.1016/j.jash.2007.10.005
Jessup, Jewell A, et al. "Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats." Journal of the American Society of Hypertension : JASH vol. 2,2 (2008): 106-15. doi: https://doi.org/10.1016/j.jash.2007.10.005
Jessup JA, Brosnihan KB, Gallagher PE, Chappell MC, Ferrario CM. Differential effect of low dose thiazides on the Renin Angiotensin system in genetically hypertensive and normotensive rats. J Am Soc Hypertens. 2008 Mar-Apr;2(2):106-15. doi: 10.1016/j.jash.2007.10.005. PMID: 19343087; PMCID: PMC2409168.
Copy Download .nbib Format: NLM
Erratum to: Local intra-uterine Ang-(1-7) infusion attenuates PGE2 and 6-keto PGF1α in decidualized uterus of pseudopregnant rats.

Reproductive biology and endocrinology : RB&E

Brosnihan KB, Pulgar VM, Bharadwaj MS, Neves LA, Yamaleyeva LM.
PMID: 28347298
Reprod Biol Endocrinol. 2017 Mar 27;15(1):22. doi: 10.1186/s12958-017-0238-5.

No abstract available.

Cite
Brosnihan KB, Pulgar VM, Bharadwaj MS, et al. Erratum to: Local intra-uterine Ang-(1-7) infusion attenuates PGE2 and 6-keto PGF1α in decidualized uterus of pseudopregnant rats. Reprod Biol Endocrinol. 2017;15(1):22doi: 10.1186/s12958-017-0238-5.
Brosnihan, K. B., Pulgar, V. M., Bharadwaj, M. S., Neves, L. A., & Yamaleyeva, L. M. (2017). Erratum to: Local intra-uterine Ang-(1-7) infusion attenuates PGE2 and 6-keto PGF1α in decidualized uterus of pseudopregnant rats. Reproductive biology and endocrinology : RB&E, 15(1), 22. https://doi.org/10.1186/s12958-017-0238-5
Brosnihan, K Bridget, et al. "Erratum to: Local intra-uterine Ang-(1-7) infusion attenuates PGE2 and 6-keto PGF1α in decidualized uterus of pseudopregnant rats." Reproductive biology and endocrinology : RB&E vol. 15,1 (2017): 22. doi: https://doi.org/10.1186/s12958-017-0238-5
Brosnihan KB, Pulgar VM, Bharadwaj MS, Neves LA, Yamaleyeva LM. Erratum to: Local intra-uterine Ang-(1-7) infusion attenuates PGE2 and 6-keto PGF1α in decidualized uterus of pseudopregnant rats. Reprod Biol Endocrinol. 2017 Mar 27;15(1):22. doi: 10.1186/s12958-017-0238-5. PMID: 28347298; PMCID: PMC5368991.
Copy Download .nbib Format: NLM
Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic.

The Journal of invasive cardiology

Talmor N, Ramachandran A, Brosnahan SB, Shah B, Bangalore S, Razzouk L, Attubato M, Feit F, Thompson C, Smilowitz NR.
PMID: 34866048
J Invasive Cardiol. 2022 Jan;34(1):E32-E38. Epub 2021 Dec 05.

BACKGROUND: The initial wave of the coronavirus disease 2019 (COVID-19) pandemic resulted in an influx of patients with acute viral illness and profound changes in healthcare delivery in New York City. The impact of this pandemic on the presentation...

Cite
Talmor N, Ramachandran A, Brosnahan SB, et al. Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. J Invasive Cardiol. 2021;34(1):E32-E38
Talmor, N., Ramachandran, A., Brosnahan, S. B., Shah, B., Bangalore, S., Razzouk, L., Attubato, M., Feit, F., Thompson, C., & Smilowitz, N. R. (2022). Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. The Journal of invasive cardiology, 34(1), E32-E38.
Talmor, Nina, et al. "Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic." The Journal of invasive cardiology vol. 34,1 (2022): E32-E38.
Talmor N, Ramachandran A, Brosnahan SB, Shah B, Bangalore S, Razzouk L, Attubato M, Feit F, Thompson C, Smilowitz NR. Invasive Management of Acute Myocardial Infarctions During the Initial Wave of the COVID-19 Pandemic. J Invasive Cardiol. 2022 Jan;34(1):E32-E38. Epub 2021 Dec 05. PMID: 34866048.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 15 entries